Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pulmonology > Pneumonia > Flashcards

Pneumonia Flashcards

1
Q

The constitution of the lung microbiota is determined by three factors: ____

A

microbial entry into the lungs

microbial elimination,

regional growth conditions for bacteria, such as pH, oxygen tension, and temperature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inflammatory mediators that cause fever

A

IL6
TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inflammatory mediators that increase local neutrophil numbers

A

IL8
GCSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiovascular events with pneumonia, particularly in the elderly and usually in association with ____ and ____, are increasingly recognized.

A

pneumococcal pneumonia

influenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What stage?
A proteinaceous exudate and often bacteria in the alveoli.

A

Edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What stage?
Erythrocytes in the intraalveolar exudate

A

Red Hepatization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What stage?
Neutrophil dominance.

A

Gray Hepatization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What stage?
Corresponds to successful infection containment and improved gas exchange.

A

Gray Hepatization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What stage?
The macrophage reappears as the dominant cell in the alveolar space

A

Resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What pattern of pneumonia is common in nosocomial pneumonias

A

Bronchopneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lobar pattern is more common in ___

A

bacterial CAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Increasing Incidence of
____ and ____ particularly in young adults.

A

M. pneumoniae
C. pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common viral pathogens: ___

A

Influenza, parainfluenza, respiratory syncytial virus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aspiration pneumonia was historically associated with ___

A

anaerobes

Anaerobes remain relevant in:
Poor dentition.
Lung abscess.
Necrotizing pneumonia.
Empyema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A primary etiologic agent of CAP

A

MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk Factors for CAP

A

Alcoholism.
Asthma.
Immunosuppression.
Institutionalization.
Age >70 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Elderly-Specific Risk Factors

A

Decreased cough and gag reflexes.
Reduced antibody and Toll-like receptor responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Risk factors for Pneumococcal Pneumonia:

A

Dementia.
Seizure disorders.
Heart failure.
Cerebrovascular disease.
Alcoholism.
Tobacco smoking.
Chronic obstructive pulmonary disease (COPD).
HIV infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk factors for Enterobacteriaceae Infections:

A

Recent hospitalization.
Recent antibiotic use.
Comorbidities:
Alcoholism.
Heart failure.
Renal failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Risk factors for Pseudomonas aeruginosa Infections:

A

Severe structural lung disease:
Bronchiectasis.
Cystic fibrosis.
Severe COPD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Risk factors for Legionalla Pneumonoa

A

Diabetes.
Hematologic malignancy.
Cancer.
Severe renal disease.
HIV infection.
Smoking.
Male gender.
Recent hotel stay or cruise ship travel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CXR pneumotoceles

A

S Aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CXR Upper lobe cavitating lesion

A

TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

To be suitable, a sputum sample must have ___ neutrophils and ___ squamous epithelial cells per low-power field.

A

> 25
<10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Can detect antigen even after the initiation of a priate antibiotic therapy.

A

Urinary Antigen Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

PCR of nasopharyngeal swabs has become the standard for diagnosis of _____

A

respiratory viral infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Two of the most commonly used markers are ___

A

C-reactive protein (CRP) and procalcitonin (PCT).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

A prognostic model that identifies patients at low risk of dying,

A

PSI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

____ yield a severity-of-illness score

A

CURB-65 Criteri

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

PSI Class: Outpatient management

A

Class 1 and 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

PSI Class: Observation unit or outpatient management with close follow-up.

A

Class 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

PSI Class: Inpatient admission required.

A

Class 4 and 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

CURB-65 Criteria

A

C: Confusion.
U: Urea >7 mmol/L.
R: Respiratory rate ≥30/min.
B: Blood pressure (systolic ≤90 mmHg or diastolic ≤60 mmHg).
65: Age ≥65 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

CURB 65 Score 0

A

Outpatient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

CURB 65 Score 1-2

A

Hospitalization unless score is due solely to age ≥65 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

CURB 65 Score ≥3

A

Mortality rate 22% → Consider ICU admission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Necessary to admit patients with Oxygen saturation of ___ on room air.

A

<92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

The S. pneumoniae minimal inhibitory concentration (MIC) breakpoint cutoffs for penicillin in pneumonia are:
____ for susceptible
_____ for intermediate
____ for resistant

A

≤2 μg/mL
>2–4 μg/mL
≥8 μg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Target-site modification caused by ribosomal methylation in 23S rRNA encoded by the ___ gene results in high-level resistance (MIC, ≥64 μg/mL

A

ermB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

The efflux mechanism encoded by the ___ gene (M phenotype) is usually associated with low-level resistance (MIC, 1–32 μg/mL).

A

mef

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

The most important risk factor for antibiotic-resistant pneumococcal infection is _____

A

use of a specific antibiotic within the previous 3 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Risk factors for penicillin-resistant pneumococcal infection include ______

A

recent antimicrobial therapy
an age of <2 or >65 years
attendance at a day-care center recent hospitalization
HIV infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Methicillin resistance in S. aureus is determined by the ___ gene, which encodes for resistance to all β-lactam drugs.

A

mecA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

The typical hospital-acquired strain usually has a type II or III SCCmec element, whereas CA-MRSA has type ___.

A

IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Mycoplasma resistance to ____ is increasing as a result of binding-site mutation in domain V of 23S rRNA.

A

macrolides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Extended-spectrum β-lactamase (ESBL) producers:
Require ___ therapy.

A

carbapenem

47
Q

A 62-year-old man presents with nonsevere CAP. He has no history of prior respiratory isolation of MRSA or Pseudomonas aeruginosa. However, he was hospitalized 2 months ago and received IV antibiotics. According to the algorithm, which of the following is the best next step?

A. Add treatment for Pseudomonas aeruginosa.
B. Obtain cultures before adding treatment for resistant pathogens.
C. Add treatment for MRSA and Pseudomonas aeruginosa.
D. No additional treatment is required.

A

B

48
Q

Which of the following factors is considered a stronger risk factor for infection with MRSA or Pseudomonas aeruginosa in hospitalized CAP patients?

A. Recent hospitalization and IV antibiotic use.
B. Underlying lung disease such as bronchiectasis or severe COPD.
C. Prior respiratory isolation of MRSA or Pseudomonas aeruginosa.
D. Local validation of high prevalence of resistant pathogens.

A

C

49
Q

A 72-year-old man with severe COPD is hospitalized for nonsevere CAP. He has no history of prior respiratory isolation of resistant organisms but was hospitalized 3 months ago and received antibiotics. What is the recommended approach?

A. Add empirical treatment for Pseudomonas aeruginosa.
B. Obtain cultures and withhold treatment for resistant organisms unless positive.
C. Add treatment for MRSA only.
D. Withhold cultures and continue standard therapy.

A

B

50
Q

Regardless of the site of care, CAP patients testing positive for influenza should be given anti-influenza treatment (e.g., oseltamivir) as well as appropriate antibacterial therapy. T/F

A

T

51
Q

Fever and leukocytosis usually resolve within ____days in otherwise healthy patients with CAP, but physical findings may persist longer.

A

2–4

52
Q

Chest radiographic abnormalities are slowest to resolve (____ weeks), with the speed of clearance depending on the patient’s age and underlying lung disease.

A

4-12 weeks

53
Q

For a hospitalized patient, we generally recommend a follow-up radiograph ~____weeks later.

A

4–6

54
Q

If relapse or recurrence is documented, particularly in the same lung segment, the possibility of an underlying ____ must be considered.

A

neoplasm

55
Q

Young patients without c bidity do well and usually recover fully after ~___ weeks.

A

2

56
Q

As a general rule, when initiating treatment for infection with P. aeruginosa, we use ______.

A

double coverage

57
Q

The presence of all three risk factors is not required for drug resistance (recent hospitalization, recent oral or IV antibiotic treatment, ± local validation) T/F

A

T

58
Q

Outpatient: As a rule, however, we usually tend to initiate treatment that includes coverage for ____ as well as the ____ (Table 126-4).

A

S. pneumoniae
atypical pathogens

59
Q

Monotherapy with a macrolide is recommended in the new guidelines only if there are contraindications to amoxicillin or doxycycline and there is documented low risk of macrolide resistance (____).

A

<25%

60
Q

A 45-year-old man with CAP and no comorbidities is found to have a local prevalence of macrolide-resistant Streptococcus pneumoniae >25%. Which of the following treatment regimens is most appropriate?

A. Macrolide monotherapy.
B. Doxycycline monotherapy.
C. Amoxicillin/clavulanate + doxycycline.
D. Respiratory fluoroquinolone monotherapy.

A

B

61
Q

A 72-year-old man with stable vital signs with a history of heart failure and asplenia presents with CAP. He is allergic to penicillin. Which of the following is the most appropriate initial treatment?

A. Doxycycline monotherapy.
B. Respiratory fluoroquinolone monotherapy.
C. Amoxicillin monotherapy.
D. Macrolide monotherapy.

A

B

62
Q

A 60-year-old man with no comorbidities is admitted to the hospital with nonsevere CAP. He has no history of MRSA or Pseudomonas aeruginosa infection. Which of the following is the most appropriate empirical therapy?

A. A β-lactam + a macrolide.
B. A β-lactam + vancomycin.
C. A respiratory fluoroquinolone + linezolid.
D. Amoxicillin monotherapy.

A

A

63
Q

A 55-year-old woman with severe CAP is admitted to the ICU. She was recently hospitalized and treated with IV antibiotics for a urinary tract infection. According to the table, what is the best initial approach?

A. Add coverage for MRSA and Pseudomonas aeruginosa immediately.
B. Add coverage for MRSA and Pseudomonas aeruginosa only if cultures are positive.
C. Initiate treatment with a β-lactam + a macrolide only
D. Start empirical treatment with a respiratory fluoroquinolone only.

A

A

64
Q

A 70-year-old man with bronchiectasis and severe CAP is admitted to the hospital. He has no history of prior isolation of Pseudomonas aeruginosa. What should be the next step in managing this patient?

A. Add empirical coverage for Pseudomonas aeruginosa.
B. Initiate standard treatment with a β-lactam + a macrolide.
C. Use a β-lactam + doxycycline.
D. Add MRSA coverage with vancomycin.

A

A
P. aeruginosa is a particular problem in patients with severe structural lung disease (e.g., bronchiectasis, cystic fibrosis, or severe COPD).

65
Q

The most important distinction is that CA-MRSA strains also carry genes for superantigens such as enterotoxins B and C and ____; the latter is a membrane-tropic toxin that can create cytolytic pores in neutrophils, monocytes, and macrophages.

A

Panton-Valentine leukocidin

66
Q

[CPG] As soon as diagnosis is established, treatment of community acquired pneumonia, regardless of risk, should be initiated within __ hours.

A

4

67
Q

[CPG] Among patients with low to moderate risk CAP, a treatment duration of ___ days is recommended as long as the patient is clinically stable (afebrile within 48 hours, able to eat, normal blood pressure, normal heart rate, normal respiratory rate, normal oxygen saturation, and return to baseline sensorium).

A

5

68
Q

[CPG] Among adult patients who are being treated for community-acquired pneumonia and who are clinically improving, follow up chest x-ray should NOT routinely be performed to monitor response to treatment. T/F

A

T

69
Q

[CPG] We recommend posttreatment chest x-rays after a minimum of ___weeks among patients with CAP to establish baseline and to exclude other conditions.

A

6 to 8

70
Q

_____ may be used to guide antibiotic discontinuation among patients with moderate or high risk CAP.

A

Procalcitonin

71
Q

[CPG] Pneumococcal polysaccharide vaccine (PPSV) or pneumococcal conjugate vaccine (PCV) are recommended for the prevention of invasive pneumococcal disease in adults ____.

A

50 years old and older

72
Q

[CPG] Pneumococcal polysaccharide vaccine is recommended for adults to prevent _____.

A

(a) pneumococcal pneumonia, (b) mortality from IPD or pneumonia and (c) pneumonia among high-risk groups and adults 50 years and above

73
Q

[CPG] Treatment
Low Risk CAP wo Comorbidities

A

Amoxicillin 1 gram, three times daily (Strong recommendation, low quality of evidence)

OR Clarithromycin 500mg, twice daily

OR Azithromycin 500mg once daily (Strong Recommendation, low quality of evidence)

74
Q

[CPG] Treatment Patients with low risk CAP with stable comorbidities

A

Co-amoxiclav (amoxicillin/clavulanate 500 mg/125 mg three times daily, OR amoxicillin/ clavulanate 875 mg/125 mg twice daily)
OR

Cefuroxime 500mg, twice daily (Strong recommendation, moderate quality of evidence)

PLUS OR MINUS (+/-)

Clarithromycin 500mg, twice daily

OR Azithromycin 500mg once daily recommendation, low quality of evidence)

(Strong

OR Doxycycline 100mg, twice daily (Conditional recommendation, low quality of evidence)

75
Q

Patients with moderate risk CAP without MDRO infection

A

Non-pseudomonal Beta-lactam antibiotic Ampicillin-sulbactam 1.5–3 g every 6 h OR Cefotaxime 1–2 g every 8 h OR Ceftriaxone 1–2 g daily

PLUS Macrolide Azithromycin 500 mg daily OR Clarithromycin 500 mg twice daily) (Strong recommendation, moderate quality of

76
Q

Patients with high risk CAP without MDRO infection

A

FIRST LINE THERAPY Non-pseudomonal Beta-lactam antibiotic

Ampicillin-sulbactam 1.5–3 g IV every 6 h OR Cefotaxime 1–2 g IV every 8 h

OR

Ceftriaxone 1–2 g IV daily

PLUS Macrolide Azithromycin 500 mg PO/IV daily

OR Erythromycin 500 mg PO every 6 hours

OR Clarithromycin 500 mg PO twice daily (Strong recommendation, low quality of evidence

77
Q

Patients with high risk CAP without MDRO infection ALT therapy

A

ALTERNATIVE THERAPY Non-pseudomonal Beta-lactam antibiotic

PLUS Respiratory fluoroquinolone* Levofloxacin 750 mg PO/IV daily OR Moxifloxacin 400 mg PO/IV daily (Conditional recommendation, low quality of evidence) * given as 1 hour IV infusion

78
Q

Risk for Methicillin Resistant Staphylococcus aureus (MRSA)

A

Prior colonization or infection with MRSA within 1 year

  • Intravenous antibiotic therapy within 90 days
79
Q

[CPG] Risk for Methicillin Resistant Staphylococcus aureus (MRSA) Treatment

A

Non-pseudomonal Beta lactam antibiotic PLUS Macrolide

OR
respiratory fluoroquinolone*

PLUS
Vancomycin 15 mg/kg IV every 12 hours^ OR Linezolid 600 mg IV every 12 hours ^ OR Clindamycin 600 mg IV every 8 hours^

80
Q

[CPG] Risk for Pseudomonas aeruginosa

A

Prior colonization or infection with P aeruginosa within 1 year

Severe bronchopulmonary disease (severe COPD, bronchiectasis, prior tracheostomy)

81
Q

[CPG] Risk for Pseudomonas aeruginosa Treatment

A

Piperacillin-Tazobactam 4.5g IV every 6 hours OR Cefepime 2 g IV every 8 hours OR Ceftazidime 2 g IV every 8 hours OR Aztreonam 2 g IV every 8 hours OR Meropenem 1 g IV every 8 hours (especially if with ESBL risk)

PLUS Macrolide OR respiratory fluoroquinolone*

82
Q

[CPG] Risk for ESBL Treatment

A

Ertapenem 1g IV every 24 hours OR Meropenem 1 g IV every 8 hours (if Ertapenem is not available)

PLUS Macrolide OR respiratory fluoroquinolone*

83
Q

If diagnostic tests are not accessible, empiric antiviral therapy may be considered in addition to antibacterial therapy during periods of high influenza activity ____ among patients with high risk CAP preceded by influenza-like illness symptoms (___) and any of the following risk factors: ____

A

(July to January)
sore throat, rhinorrhea, body malaise, joint pains)

Aged 60 years and above Pregnant Asthmatic Other co-morbidities: uncontrolled diabetes mellitus, active malignancies, neurologic disease in evolution, congestive heart failure class II-IV, unstable coronary artery disease, renal failure on dialysis, uncompensated COPD, decompensated liver disease

84
Q

What is the recommended initial treatment for low-risk CAP without co-morbidities?
A. Amoxicillin 1g three times daily
B. Ceftriaxone 1g IV once daily
C. Levofloxacin 750mg once daily
D. Meropenem 1g IV every 8 hours

A

A

85
Q

Which of the following findings indicates high-risk CAP according to the guideline?
A. Temperature of 37.5°C
B. Pulse rate of 110 beats/minute
C. Respiratory rate of 28 breaths/minute
D. Systolic blood pressure < 90 mmHg

A

D

86
Q

Which of these is recommended for empiric treatment of high-risk CAP without multi-drug-resistant organism (MDRO) infection?
A. Ceftriaxone + Azithromycin
B. Piperacillin-Tazobactam + Ciprofloxacin
C. Vancomycin + Meropenem
D. Ceftazidime + Amikacin

A

A

87
Q

When should Gram stain and culture of respiratory secretions be performed in CAP?
A. In all patients with CAP
B. Only in patients with low-risk CAP
C. In moderate- to high-risk CAP or suspected MDRO infection
D. Only when there is severe sepsis

A

C

88
Q

According to the guidelines, how soon should treatment for CAP be initiated after diagnosis?
A. Within 8 hours
B. Within 6 hours
C. Within 4 hours
D. Within 12 hours

A

C

89
Q

Which of the following is NOT a recommended first-line antibiotic for low-risk CAP with co-morbid conditions?
A. Co-amoxiclav
B. Cefuroxime
C. Doxycycline
D. Levofloxacin

A

D

90
Q

In what setting should blood cultures be obtained for CAP management?
A. All cases of CAP
B. Only in severe sepsis
C. Moderate- to high-risk CAP cases
D. Only after treatment failure

A

C

91
Q

A 45-year-old woman with no prior medical history presents with cough, fever, and pleuritic chest pain for three days. Her vitals are stable except for a temperature of 38.2°C. Chest X-ray shows right lower lobe consolidation. Which antibiotic regimen is most appropriate?
A. Doxycycline 100mg twice daily
B. Amoxicillin 1g three times daily
C. Cefuroxime 500mg twice daily + Clarithromycin 500mg twice daily
D. Meropenem 1g IV every 8 hours

A

B

92
Q

A 68-year-old man with diabetes presents with fever, cough, and confusion. His temperature is 35.5°C, respiratory rate 30/min, and blood pressure 85/55 mmHg. What is the recommended first step in management?
A. Obtain chest X-ray only
B. Start antibiotics after cultures return
C. Start IV antibiotics immediately
D. Order respiratory viral panel and wait for results

A

C

93
Q

A 58-year-old patient with high-risk CAP tests positive for influenza during peak influenza season. What is the most appropriate management?
A. Continue antibiotics only
B. Start oseltamivir in addition to antibiotics
C. Stop antibiotics and use antiviral only
D. Repeat influenza testing after 48 hours

A

B

94
Q

What should be done for patients who are not improving after 72 hours of empiric antibiotic therapy?

A

Nonresponding pneumonia or failure to improve may be due to:

  1. Incorrect diagnosis or presence of a complicating noninfectious condition e.g., pulmonary embolism, congestive heart failure, vasculitis, myocardial infarction
  2. A resistant microorganism or an unexpected pathogen that is not covered by the antibiotic choice
  3. Antibiotic is ineffective or causing an allergic reaction i.e., poor absorption of the oral antibiotic, certain drug interactions, inadequate dose, patient not taking or receiving the prescribed antibiotic
  4. Impaired local or systemic host defenses e.g., aspiration, endobronchial obstruction, bronchiectasis, systemic immune deficiency
  5. Local or distant complications of pneumonia e.g., parapneumonic effusion, empyema, lung abscess, ARDS, metastatic infection, endocarditis
  6. Overwhelming infection
  7. Slow response in the elderly patient; S. pneumoniae and L. pneumophila may cause slow resolution of pneumonia in the elderly
  8. Exacerbation of comorbid illnesses
  9. Nosocomial superinfection
95
Q

Three factors are critical in the pathogenesis of VAP: ____

A

colonization of the oropharynx with pathogenic microorganisms

aspiration of these organisms from the oropharynx into the lower respiratory tract

compromise of normal host defense mechanisms.

96
Q

_____ is a common complication among patients requiring mechanical ventilation.

A

Pneumonia

97
Q

[VAP] The most obvious risk factor is the ____, which bypasses the normal mechanical factors preventing aspiration.

A

endotracheal tube

98
Q

While the presence of an endotracheal tube may prevent large-volume aspiration, _____ is actually exacerbated by secretions pooling above the cuff.

A

microaspiration

99
Q

[VAP] Suctioning done preferably with a ____

A

closed catheter system

100
Q

[VAP]Heat moisture exchangers are changed every____days or when soiled/malfunctioning.

A

5–7

101
Q

The ventilator circuit tubing can harbor pathogenic organisms that can wash back to the patient if manipulated too often; thus circuits are changed only ____

A

when soiled and with each new patient.

102
Q

[VAP] The most important risk factors are _____

A

antibiotic selection pressure, cross-infection from other infected/colonized patients or contaminated equipment, severe systemic illness, and malnutrition.

103
Q

[VAP]____poses the greatest risk by far.

A

Antibiotic exposure

104
Q

Serial changes in ___ may identify pneumonia earlier than other findings and may also be a means to monitor improvement with therapy.

A

oxygenation

105
Q

Application of the clinical criteria typical for CAP consistently results in overdiagnosis of VAP, largely because of

A

(1) frequent tracheal colonization with pathogenic bacteria in patients with endotracheal tubes, (2) multiple alternative causes of radiographic infiltrates in mechanically ventilated patients, and (3) the high frequency of other sources of fever in critically ill patients.

106
Q

The more distal in the respiratory tree the d nostic sampling, the more specific the results and therefore the lower the threshold of growth necessary to diagnose pneumonia and exclude colonization.

A
107
Q

[VAP] Frequent use of ____ drugs, especially cephalosporins, appears to be the major risk factor for infection with MRSA and ESBL-positive strains.

A

β-lactam

cephalosporins

108
Q

[VAP] The standard recommendation for patients with risk factors for MDR infection and a high mortality risk is for ____ antibiotics

A

three antibiotics:

two directed at P. aeruginosa

one at MRSA.

109
Q

Apart from death, the major complication of VAP is _____, with corresponding increases in the duration of ICU and hospital stay.

A

prolongation of mechanical ventilation

110
Q

[VAP] Clinical improvement, if it occurs, is usually evident within ____ h of the initiation of antimicrobial treatment, usually with an improvement in oxygenation.

A

48–72

111
Q

What is the recommended vancomycin trough level for treating MRSA in HAP or VAP?

A. 5–10 mg/dL
B. 10–15 mg/dL
C. 15–20 mg/dL
D. 20–25 mg/dL

A

C

112
Q

Which of the following strategies is recommended to prevent oropharyngeal colonization with pathogenic bacteria in patients at risk for ventilator-associated pneumonia (VAP)?

A. Use of prolonged antibiotic courses
B. Oral chlorhexidine
C. Avoidance of sedatives
D. Tight glycemic control

A

B

113
Q

What is the recommended intervention for altered lower respiratory host defenses in patients on mechanical ventilation?

A. Tight glycemic control
B. Prophylactic PEEP of 10–12 cm
C. Head-of-bed elevation to 30°
D. Avoidance of sedation

A

A

114
Q
A

Pulmonology (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions